Simulations Plus
Builds drug-development simulation software and consulting services for biopharma clients.
$18.40
After-hours close0.00 (0.00%)
At close$18.40(−0.11%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | $0.11 | — | — |
| Jul 2026 | $0.23 | $0.30 | +29.0% |
| Apr 2026 | $0.27 | $0.35 | +29.6% |
| Jan 2026 | $0.18 | $0.13 | −27.8% |
| Dec 2025 | $0.10 | $0.10 | 0.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Jan 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Jan 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Jan 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Nov 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Jan 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Jan 2016 | |||
| Nov 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | $0.11 | — | — | $17.6M | — | — |
| Jul 9, 2026 | $0.23 | $0.30 | +29.0% | $20.9M | $21.9M | +4.7% |
| Apr 9, 2026 | $0.27 | $0.35 | +29.6% | $21.7M | $24.3M | +12.2% |
| Jan 8, 2026 | $0.18 | $0.13 | −27.8% | $18.1M | $18.4M | +2.0% |
| Dec 1, 2025 | $0.10 | $0.10 | 0.0% | $17.4M | $17.5M | +0.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 14, 2025 | ||||||
| Apr 3, 2025 | ||||||
| Jan 7, 2025 | ||||||
| Oct 23, 2024 | ||||||
| Jul 2, 2024 | ||||||
| Apr 3, 2024 | ||||||
| Jan 3, 2024 | ||||||
| Oct 25, 2023 | ||||||
| Jul 6, 2023 | ||||||
| Apr 5, 2023 | ||||||
| Jan 4, 2023 | ||||||
| Oct 26, 2022 | ||||||
| Jul 6, 2022 | ||||||
| Apr 6, 2022 | ||||||
| Jan 6, 2022 | ||||||
| Oct 25, 2021 | ||||||
| Jul 12, 2021 | ||||||
| Apr 12, 2021 | ||||||
| Jan 11, 2021 | ||||||
| Nov 16, 2020 | ||||||
| Jul 9, 2020 | ||||||
| Apr 9, 2020 | ||||||
| Jan 9, 2020 | ||||||
| Nov 13, 2019 | ||||||
| Jul 10, 2019 | ||||||
| Apr 9, 2019 | ||||||
| Jan 9, 2019 | ||||||
| Nov 14, 2018 | ||||||
| Jul 10, 2018 | ||||||
| Apr 9, 2018 | ||||||
| Jan 9, 2018 | ||||||
| Nov 14, 2017 | ||||||
| Jul 10, 2017 | ||||||
| Apr 10, 2017 | ||||||
| Jan 9, 2017 | ||||||
| Nov 11, 2016 | ||||||
| Jul 14, 2016 | ||||||
| Apr 13, 2016 | ||||||
| Jan 14, 2016 | ||||||
| Nov 18, 2015 | ||||||
| Jul 13, 2015 | ||||||